AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

A 43-minute MedPage Today webinar published October 30, 2026, features Editor-in-Chief Jeremy Faust interviewing bioethicist and oncologist Ezekiel J. Emanuel about whether medicine should test AI systems in more independent clinical roles. Emanuel’s case for testing raises questions about evidence, patient choice, medical education, oversight and liability; the report does not establish that AI is ready to replace doctors.

MedPage Today published a 43-minute webinar on October 30 in which Editor-in-Chief Jeremy Faust interviewed bioethicist and oncologist Ezekiel J. Emanuel about whether medicine should test artificial intelligence systems in more autonomous clinical roles. Emanuel argues that AI should not be restricted to assisting physicians, while the conversation examines the evidence, safeguards and patient choices that would matter if AI were allowed to take on more independent care decisions.

The discussion focuses on where AI might rival or outperform physicians, what human clinicians contribute to relationships with patients, and whether doctors could sometimes make AI less effective. Emanuel also addresses concerns about physicians’ jobs and how medical education might change if AI takes on a larger clinical role. The source report presents these as topics explored in the conversation, not as settled findings about AI performance or the future of medical work.

Faust and Emanuel examine what evidence would be needed before AI receives greater autonomy, who should decide whether a system is ready to practice medicine, and what role patients should have in choosing AI-driven care. Later sections of the webinar consider whether AI can account for patient preferences and judgment and who may be liable if an autonomous system makes an error.

The report identifies Emanuel as a bioethicist and oncologist at the University of Pennsylvania in Philadelphia. It does not provide study results, comparative performance data, or a policy decision authorizing autonomous AI practice. Its central development is the publication of a debate about whether such systems should be tested and what rules would be needed—not a finding that AI should replace physicians now.

At a glance
reportWhen: Published October 30, 2026
The developmentMedPage Today published a conversation in which Zeke Emanuel argues that medicine should be willing to test autonomous AI systems rather than confining them to an assistive role.

Questions for Clinical AI Trials

The conversation matters because a move from AI as a support tool to AI making decisions independently would change who exercises judgment in patient care. That shift could affect how clinicians are trained, how patients give informed consent, how health systems supervise software and how responsibility is assigned when care goes wrong. Those are practical questions for patients, clinicians and policymakers, not only technical questions about whether a system can generate a diagnosis.

Emanuel’s argument is framed around testing AI autonomy, but the source does not set out a specific trial design or establish that autonomous systems are safe or effective across medical settings. Separating the case for evaluation from proof of readiness is important: the webinar raises issues that would need answers before wider clinical use, including what performance evidence counts and whether patients can choose between AI-led and physician-led care.

Products Worth Considering

Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)

Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)

As an affiliate, we earn on qualifying purchases.

From Assistance to Autonomy

The webinar is organized around a distinction between AI that helps a physician and AI that may take on a more independent role. The report says Emanuel favors being willing to test the latter, while also discussing the limits of AI and the qualities humans bring to doctor-patient relationships. It does not describe a new medical product, regulatory approval or implementation program.

Its chapter list shows the scope of the exchange: medical training and physicians’ jobs appear alongside evidence standards, decision-making authority, patient preferences and liability. The available source is a brief report and webinar description; it supplies no transcript detail or outcome data from a clinical test. The conversation is therefore best understood as a discussion of policy and professional questions, rather than a report that AI has been authorized to practice independently.

“Medicine should be willing to test autonomous artificial intelligence systems rather than limiting the technology to an assistive role.”

— Ezekiel J. Emanuel, as summarized by MedPage Today

Evidence and Accountability Remain Open

The source does not say which AI systems Emanuel believes could outperform physicians, in which specialties or under what conditions. It also gives no trial results, thresholds for acceptable performance, or details on how testing should be overseen. The report’s wording that AI may rival or outperform physicians is a possibility discussed in the webinar, not a confirmed general finding.

It is also unclear what level of patient consent or choice Emanuel proposes, who would determine that a system is qualified to practice, and how responsibility would be divided among developers, health systems and clinicians after an error. The report does not indicate that existing rules have changed or that a decision on autonomous AI practice has been made.

Standards Before Wider Clinical Use

The next steps raised by the discussion are questions for evidence gathering and policy: how to evaluate systems in real clinical settings, who should set readiness standards, and what safeguards should apply to patient choice and accountability. The supplied report does not announce a particular study, regulatory review or implementation timetable, so no specific milestone is confirmed.

For now, the webinar provides a framework for debate rather than a change in clinical practice. Any future move toward more autonomous care would depend on evidence and decisions not described in the report, including how systems perform for different patients and how oversight and liability are handled.

Key Questions

Did MedPage Today report that AI is replacing doctors?

No. It published a webinar discussion about whether medicine should test more autonomous AI. The report does not say AI has been approved or shown to replace physicians in routine care.

What is Emanuel’s position on medical AI?

According to MedPage Today, Emanuel argues that medicine should be willing to test autonomous AI systems, rather than limiting AI to an assistive role. The report does not provide a detailed testing plan.

What questions does the conversation raise for patients?

It considers whether patients should be able to choose AI-driven care and whether AI can account for individual preferences and judgment. The source does not specify a proposed consent process.

What remains unresolved about AI errors?

The webinar raises who would be liable when autonomous AI makes a mistake. The report does not identify a legal standard or say how responsibility would be divided among clinicians, health systems and technology developers.

Source: medpagetoday.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

المانع تتوسع في الرياض بـ4 مشاريع صحية تتجاوز 700 سرير – Dawaa News MENA

شركة المانع تتوسع في الرياض بإطلاق 4 مشاريع صحية جديدة توفر أكثر من 700 سرير، لتعزيز القطاع الصحي في العاصمة السعودية.

Millions Take Fish Oil For Brain Health. A Two-year Study Found No Benefit

A placebo-controlled study of 365 older adults found no measurable cognitive or hippocampal benefit from daily DHA supplements over two years.

Adults With ADHD Face Higher Risk Of Developing Dementia Later In Life

A U.S. study of more than 187,000 adults found an association between ADHD and later cognitive impairment, but it does not show ADHD causes dementia.

Fosun Pharma Surges In Global Coverage

Fosun Pharma is experiencing a surge in international coverage, with media mentions increasing significantly. The reasons behind this spike remain unconfirmed.